Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

KORU Medical Systems, Inc. - Common Stock (NQ:KRMD)

4.440 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 4.440
Bid (Size) 4.200 (100)
Ask (Size) 4.560 (900)
Prev. Close 4.440
Today's Range 4.440 - 4.440
52wk Range 2.625 - 6.608
Shares Outstanding 46,322,655
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Koru Medical (KRMD) Q1 2026 Earnings Transcript ↗
Koru Medical (KRMD) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics World Trade
KORU Medical Systems (NASDAQ:KRMD) Soars 16% After Q1 Earnings Beat ↗
Via Chartmill

Performance

YTD
-20.9%
-20.9%
1 Month
+4.7%
+4.7%
3 Month
-8.8%
-8.8%
6 Month
+12.1%
+12.1%
1 Year
+63.2%
+63.2%

More News

Read More
News headline image
KORU Medical Systems Announces First Quarter 2026 Results
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical (KRMD) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
Topics World Trade
KORU Medical Systems Inc (NASDAQ:KRMD) Shows Minervini Trend Template and Growth Momentum Alignment ↗
Via Chartmill
News headline image
Earnings Scheduled For November 12, 2025 ↗
Via Benzinga
News headline image
KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems Announces CEO Transition
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems to Participate in Upcoming Investor Conferences
From KORU Medical Systems
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy
Via ACCESS Newswire
News headline image
ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy
From ForCast Orthopedics, Inc.
Via Business Wire
News headline image
Cirtec Medical Announces Appointment of New Chief Executive Officer
From Cirtec Medical
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga

Frequently Asked Questions

Is KORU Medical Systems, Inc. - Common Stock publicly traded?
Yes, KORU Medical Systems, Inc. - Common Stock is publicly traded.
What exchange does KORU Medical Systems, Inc. - Common Stock trade on?
KORU Medical Systems, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for KORU Medical Systems, Inc. - Common Stock?
The ticker symbol for KORU Medical Systems, Inc. - Common Stock is KRMD on the Nasdaq Stock Market
What is the current price of KORU Medical Systems, Inc. - Common Stock?
The current price of KORU Medical Systems, Inc. - Common Stock is 4.440
When was KORU Medical Systems, Inc. - Common Stock last traded?
The last trade of KORU Medical Systems, Inc. - Common Stock was at 05/07/26 04:00 PM ET
What is the market capitalization of KORU Medical Systems, Inc. - Common Stock?
The market capitalization of KORU Medical Systems, Inc. - Common Stock is 205.67M
How many shares of KORU Medical Systems, Inc. - Common Stock are outstanding?
KORU Medical Systems, Inc. - Common Stock has 206M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.